U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 491

Tests names and labsConditionsGenes, analytes, and microbesMethods

ProstateNow

GoPath Diagnostics
United States
414
  • D Deletion/duplication analysis

Expedio Hereditary Cancer Predisposition Screening Assay

Kailos Genetics
United States
4031
  • C Sequence analysis of the entire coding region

Guardant360 TissueNext

Guardant Health
United States
185
  • M Methylation analysis
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Guardant360 Response

Guardant Health
United States
174
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Hereditary Prostate Cancer Panel

QDx Pathology Services, Inc.
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Prostate Cancer Panel

QDx Pathology Services, Inc.
United States
416
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Gastric Cancer Panel

QDx Pathology Services, Inc.
United States
46
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Panel

QDx Pathology Services, Inc.
United States
619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome

QDx Pathology Services, Inc.
United States
55
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Breast and Ovarian Cancer Panel

QDx Pathology Services, Inc.
United States
323
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

QDx Pathology Services, Inc.
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NeXT Dx

Personalis, Inc.
United States
1413
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
3930
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Guardant360

Guardant Health
United States
184
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

MLH1 Related Lynch Syndrome

Molecular Genetics Laboratory London Health Sciences Centre
Canada
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Management Panel

BioReference Health
United States
4717
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Guideline Panel

BioReference Health
United States
7154
  • C Sequence analysis of the entire coding region

OnkoRisk Women's Hereditary Cancer Panel

BioReference Health
United States
3418
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Urology Panel

BioReference Health
United States
2719
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 491

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.